ACNT Q1 2025 Earnings EPS Misses Estimates Amid Market Challenges ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains WLY Q1 2026 Earnings EPS Beats Estimates by 1167 BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Bone Biologics Advances Development SRFM Q1 2026 Earnings EPS Beats Estimate by 263 as Revenue Remains Undisclosed LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited